Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAR2 Class: Corporate Bond - Foreign US$

Holders for Q4 2025 Position Changes for Q4 2025

Note: Option positions (PUT/CALL) are excluded.

InstitutionSharesValue ($000)
Pacer Advisors, Inc.75,000$86
Total (1 institutions)75,000$86